Author: GlobeNewswire

CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies,…

Scientific Data Outlines the Role of the Oral Mucosa in the Delivery of Peanut Allergy ImmunotherapyNEW YORK, July 22, 2021…

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical…

ROCKVILLE, Md., July 22, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…

SPARTA, N.J., July 22, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical…

SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter…

Research to be presented highlighting potential of neuropsychological biomarkers to guide the clinical development of Cyclerion’s investigational therapeuticsCAMBRIDGE, Mass., July…

LEXINGTON, Mass., July 22, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,…

MIRAMAR, Fla., July 22, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (NASDAQ:HCWB) (the “Company”), an innovative preclinical stage biopharmaceutical company…

— Based on latest analyses, company is revising ADVM-022 development plan to focus on wet AMD and low doses (2 x…